
Kenya's Pharmacy and Poisons Board warns public about counterfeit Postinor-2 emergency contraceptive
The Pharmacy and Poisons Board PPB has issued a public alert regarding a falsified batch of Postinor-2 emergency contraceptive tablets circulating in Kenya. The counterfeit product, labeled Batch No. T34197R, falsely claims to be manufactured by Gedeon Richter Plc. PPB CEO Dr. Ahmed Mohamed stated that the fake batch may contain incorrect amounts of active ingredients, no active ingredients, harmful contaminants, or undeclared substances, posing significant health risks and potentially failing to provide the intended therapeutic effect. The PPB identified the fake batch through post-marketing surveillance. Key differences in the counterfeit product include a distinct batch-printing technique, a patient information leaflet with typographical errors, a non-standard sealing method, a more intense orange color, and a different font for the logo on the authentication panel. Two individuals have been arrested in connection with the fake batch, and investigations are ongoing to determine its origin and distribution. This alert comes as the Kenyan government intensifies its efforts against substandard and counterfeit medicines, with Health Cabinet Secretary Aden Duale inaugurating an Interministerial Steering Committee in July 2026. Between 2021 and 2025, the PPB recorded 1,413 product quality complaints and issued 18 public alerts on suspected falsified medicines. Healthcare professionals are advised to verify stock authenticity and quarantine suspicious consignments. The public can



